Select plasma oxylipins as potential biomarkers of effective indomethacin treatment response in preterm infants with patent ductus arteriosus.

Nguyen KCK, Yeung CHT, Scott A, Velenosi TJ, Lewis T.

Open source

DOI
10.1007/s11306-026-02510-9
Published
2026-07-31
Container
Metabolomics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11306-026-02510-9,
  title = {Select plasma oxylipins as potential biomarkers of effective indomethacin treatment response in preterm infants with patent ductus arteriosus.},
  author = {Nguyen KCK and  Yeung CHT and  Scott A and  Velenosi TJ and  Lewis T.},
  year = {2026},
  journal = {Metabolomics},
  doi = {10.1007/s11306-026-02510-9},
  url = {https://doi.org/10.1007/s11306-026-02510-9}
}

RIS

TY  - JOUR
TI  - Select plasma oxylipins as potential biomarkers of effective indomethacin treatment response in preterm infants with patent ductus arteriosus.
AU  - Nguyen KCK
AU  -  Yeung CHT
AU  -  Scott A
AU  -  Velenosi TJ
AU  -  Lewis T.
PY  - 2026
JO  - Metabolomics
DO  - 10.1007/s11306-026-02510-9
UR  - https://doi.org/10.1007/s11306-026-02510-9
ER  - 

APA

KCK, N., CHT, Y., A, S., TJ, V., & T., L. (2026). Select plasma oxylipins as potential biomarkers of effective indomethacin treatment response in preterm infants with patent ductus arteriosus.. Metabolomics. https://doi.org/10.1007/s11306-026-02510-9

Source records